Security key
92337R101
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Class A Common Stock, par value $0.001 per share
- Total 13F shares
- 37,354,429
- Total 13F value
- $289,749,836
- Share change
- +18,982,135
- Put/Call ratio
- 140%
- SEC-reported price per share
- $7.76
- Number of holders
- 69
- Value change
- +$137,641,985
- Number of buys
- 51
- Number of sells
- 19
- Shares outstanding
- 72,325,000
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
69
Top holders
10
VERA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92337R101
Recent filing periods:
Ownership snapshot
Top reported holders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 5.7%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 5.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
5.7%
Sofinnova Investments, Inc.
4.4%
Abingworth LLP
4.1%
CITADEL ADVISORS LLC
2.8%
Kynam Capital Management, LP
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
5.7%
|
$80,276,301
4,148,646 shares
|
— | 31 Dec 2022 |
| Sofinnova Investments, Inc. |
13F
Company
|
4.4%
|
$61,560,903
3,181,442 shares
|
— | 31 Dec 2022 |
| Abingworth LLP |
13F
3/4/5
Company · 10%+ Owner
|
4.1%
|
$57,280,470
2,960,231 shares
|
— | 31 Dec 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.8%
|
$38,535,003
1,991,473 shares
|
— | 31 Dec 2022 |
| Kynam Capital Management, LP |
13F
Company
|
1.9%
|
$27,266,046
1,409,098 shares
|
— | 31 Dec 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.5%
|
$21,452,000
1,108,649 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
69
Shares
37,354,429
Rows available
69
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
57
Q1 2023 holders
69
Holder diff
12
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend